Partly granted
The Board restored the 100 percent rating for prostate cancer from August 1, 2022 to November 28, 2022 and denied a compensable rating for hypothyroidism. The effective date for TDIU was dismissed as moot.
The deciding factor: The evidence did not show improvement in the Veteran's ability to function under ordinary conditions of life and work for prostate cancer, while there were no attributable symptoms or residuals for thyroid condition.
- Claimed conditions
- prostate cancer, hypothyroidism
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- March 4, 2025
- Citation
- A25019358
Want to see how appeals like this one tend to go? Appeals like mine
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.